Home Stock

Stock Research: Pro Medicus

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Pro Medicus

ASX:PME AU000000PME8
50
  • Value
    10
  • Growth
    74
  • Safety
    Safety
    11
  • Combined
    18
  • Sentiment
    49
  • 360° View
    360° View
    50
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Pro Medicus Limited is a healthcare informatics company providing medical imaging software and services. It operates in the medical imaging software industry with products like Visage RIS, Visage 7, and Visage Ease. The company serves hospitals, imaging centers, and healthcare groups in Australia, North America, and Europe. In the last fiscal year, the company had a market cap of $22457 million, profits of $111 million, and revenue of $111 million.

more
Strongest Rank Price vs. Sales (P/S)
Weakest Rank Revenue Growth
Country Australia
Industry Health Care Technology
Size Small
Website promed.com.au
Index
ASX 200
ASX 300
Pro Medicus stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
10 5 10 17
Growth
74 99 97 87
Safety
Safety
11 11 83 83
Sentiment
49 81 66 54
360° View
360° View
50 50 78 62
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
25 5 15 13
Opinions Change
71 91 40 50
Pro Holdings
n/a 83 84 42
Market Pulse
83 82 89 90
Sentiment
49 81 66 54
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
10 5 10 17
Growth
74 99 97 87
Safety Safety
11 11 83 83
Combined
18 18 86 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
5 3 10 14
Price vs. Earnings (P/E)
1 1 1 2
Price vs. Book (P/B)
1 1 1 3
Dividend Yield
55 48 57 64
Value
10 5 10 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
91 96 81 46
Profit Growth
70 64 60 62
Capital Growth
63 65 89 94
Stock Returns
40 99 87 81
Growth
74 99 97 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
89 91 89 73
Refinancing
10 17 11 11
Liquidity
15 15 91 91
Safety Safety
11 11 83 83

Similar Stocks

Discover high‑ranked alternatives to Pro Medicus and broaden your portfolio horizons.

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

M3

TSE:2413
Country: Japan
Industry: Health Care Technology
Size: Medium
Full Stock Analysis

Nipro

TSE:8086
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

MediPal Holdings

TSE:7459
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews